Skip to main content
Clinical Trials/ISRCTN15030282
ISRCTN15030282
Active, Not Recruiting
N/A

Improving health-related quality of life in patients with rare autoimmune liver diseases by structured peer-delivered support: a transnational effectiveness-implementation hybrid trial

niversity Medical Center Hamburg-Eppendorf0 sites472 target enrollmentJanuary 13, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity Medical Center Hamburg-Eppendorf
Enrollment
472
Status
Active, Not Recruiting
Last Updated
3 years ago

Overview

Brief Summary

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36964518/ (added 27/03/2023)

Registry
who.int
Start Date
January 13, 2023
End Date
May 31, 2025
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity Medical Center Hamburg-Eppendorf

Eligibility Criteria

Inclusion Criteria

  • Effectiveness focus:
  • 1\. Autoimmune rare liver disease (AIH, PSC, PBC)
  • 2\. Subjective psychosocial support need
  • 3\. \=18 years
  • 4\. Written informed consent
  • Implementation focus:
  • Stakeholders:
  • 1\. Involvement in intervention delivery/implementation i.e. healthcare providers, patient representatives, health insurers
  • 2\. Written informed consent

Exclusion Criteria

  • Effectiveness focus:
  • 1\. Life\-threatening health\-status
  • 2\. Acute suicidality
  • 3\. Ongoing psychotherapy
  • 4\. Severe cognitive, auditory or visual impairment
  • 5\. Inability to complete assessments
  • Implementation focus:
  • 1\. Involvement in outcome assessment or data analysis

Outcomes

Primary Outcomes

Not specified

Similar Trials